title: [New technology for prevention of embolic events in atrial fibrillation: a systematic review on percutaneous endovascular left atrial appendage closure].
abstract: Atrial fibrillation (AF) is the most common cardiac arrhythmia. The mortality rate of patients with AF is doubled as compared to non-fibrillating controls. The most relevant complication of AF is a major increase in the risk of stroke. The gold standard in reducing cerebrovascular events in AF is warfarin therapy, which is not free from contraindications and limitations. The left atrial appendage (LAA) is the main source of emboli causing stroke in AF. LAA closure is a seducing approach to stroke risk reduction in AF without anticoagulation. Since 1949, heart surgeons have performed LAA closure or amputation in patients with AF. Percutaneous endovascular LAA closure is a new, less invasive, technique to reach the goal. Several devices have been used to perform this intervention, and the results of published trials are encouraging in terms of effectiveness and relative safety of this attractive technique. In this review we examine the published trials and data on percutaneous LAA closure, with particular attention to the risks and benefits of this procedure.
authors: Dipartimento di Cardiologia, Ospedale Luigi Sacco, 20156 Milano, Italy.
authors: Paolo
authors: P
authors: Danna
authors: Antonio
authors: A
authors: Sagone
authors: Riccardo
authors: R
authors: Proietti
authors: Andrea
authors: A
authors: Arensi
authors: Maurizio
authors: M
authors: Viecca
authors: Pasquale
authors: P
authors: Santangeli
authors: Luigi
authors: L
authors: Di Biase
authors: Andrea
authors: A
authors: Natale
mesh_terms: D020517:Atrial Appendage / Q000601:surgery*; D001281:Atrial Fibrillation / Q000150:complications*; D003663:Decision Trees; D004617:Embolism / Q000209:etiology* / Q000517:prevention & control*; D057510:Endovascular Procedures / Q000379:methods; D006801:Humans